PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells (CSM/ON/2011)
Sponsor: Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán
A PHASE2 clinical study on Osteonecrosis of the Femoral Head, this trial is completed. The trial is conducted by Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Apr 2017 — Jun 2018 [monthly]
Completed PHASE2
Status: Unknown Status → Completed
▶ Show 1 earlier version
-
Jan 2017 — Apr 2017 [monthly]
Unknown Status PHASE2
First recorded
Jul 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán
- Red de Terapia Celular
- Spanish National Health System
For direct contact, visit the study record on ClinicalTrials.gov .